Birdwatch Archive

Birdwatch Note Rating

2024-07-07 13:28:39 UTC - HELPFUL

Rated by Participant: D4C8E43BBD65DA9EABF62F8D4DE69E444BF4F0A4972C133B3A4B5B9822844DCD
Participant Details

Original Note:

El trastazumab/deruxtecán ya se encuentra financiado por el Sistema Nacional de Salud español desde 2022 para las pacientes con cáncer de mama metastásico HER2 positivo. https://www.phmk.es/industria/trastuzumab-deruxtecan-ya-esta-disponible-en-espana-para-el-tratamiento-del-cancer-de-mama-metastasico-her2-positivo#:~:text=Enhertu%20(Trastuzumab%20deruxtec%C3%A1n%20%2DT%2D,CIPM)%20el%20pasado%2027%20de

All Note Details

Original Tweet

All Information

  • noteId - 1809874085091905990
  • participantId -
  • raterParticipantId - D4C8E43BBD65DA9EABF62F8D4DE69E444BF4F0A4972C133B3A4B5B9822844DCD
  • createdAtMillis - 1720358919994
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1809874085091905990D4C8E43BBD65DA9EABF62F8D4DE69E444BF4F0A4972C133B3A4B5B9822844DCD